235 related articles for article (PubMed ID: 4362570)
1. Cholestyramine for elevated serum cholesterol.
Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
[No Abstract] [Full Text] [Related]
2. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
Glueck CJ; Tsang RC; Fallat RW; Scheel D
Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
[No Abstract] [Full Text] [Related]
3. Dietary and drug treatment of primary hyperlipoproteinemia.
Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
[No Abstract] [Full Text] [Related]
4. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
5. The primary hyperlipoproteinemias.
Bybee DE; Hamilton RD
J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
[No Abstract] [Full Text] [Related]
6. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
Glueck CJ; Tsang RC; Fallat RW; Mellies M
Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia and coronary artery disease. Prinicples of diet and drug treatment.
Kuo PT
Med Clin North Am; 1974 Mar; 58(2):351-62. PubMed ID: 4360816
[No Abstract] [Full Text] [Related]
8. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
Carlson LA; Olsson AG; Orö L; Rössner S
Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
[No Abstract] [Full Text] [Related]
9. [Cholestyramine therapy in type II hyperlipoproteinemia].
Christensen NC; Mogensen EF
Ugeskr Laeger; 1971 Dec; 133(49):2431-4. PubMed ID: 5136077
[No Abstract] [Full Text] [Related]
10. Diet and drug treatment of hyperlipidemia and atherosclerosis.
Kuo PT
Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
[No Abstract] [Full Text] [Related]
11. [Lipoproteins and hyperlipoproteinemias].
Weisweiler P; Schwandt P
Fortschr Med; 1980 Mar; 98(9):313-6. PubMed ID: 7372258
[No Abstract] [Full Text] [Related]
12. [Value of cholestyramine in the treatment of refractory diarrhea in infants and the newborn].
Blanckaert D; Farriaux JP
Nouv Presse Med; 1976 Mar; 5(11):713-4. PubMed ID: 772596
[No Abstract] [Full Text] [Related]
13. Therapy of the hyperlipoproteinemias.
Bagdade JD
Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():98-110. PubMed ID: 4605376
[No Abstract] [Full Text] [Related]
14. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
Farah JR; Kwiterovich PO; Neill CA
Adv Exp Med Biol; 1977; 82():212-5. PubMed ID: 200092
[No Abstract] [Full Text] [Related]
15. [Resins in the treatment of hypercholesterolemia].
Jacotot B
Med Chir Dig; 1978; 7(8):697-8. PubMed ID: 745469
[No Abstract] [Full Text] [Related]
16. Diet and drug therapy for hyperlipoproteinemia.
Maha GE
Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
[No Abstract] [Full Text] [Related]
17. Treatment of type II hyperlipoproteinaemia with cholestyramine.
Schade RW; Laar A van't ; Jansen AP
Neth J Med; 1973; 16(6):254-9. PubMed ID: 4767765
[No Abstract] [Full Text] [Related]
18. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
Rider AK
JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
[No Abstract] [Full Text] [Related]
19. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
Glueck CJ; Ford S; Scheel D; Steiner P
JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
[No Abstract] [Full Text] [Related]
20. [Antilipidemic agents].
Irsigler K; Flegel U
Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):334-40. PubMed ID: 5148890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
